(Q43762095)

English

Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

1

object named as

Liaw YF

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Antiviral Chemistry & Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

12 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

67-71

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43762095&oldid=2103117273"